BCL2 and cancer: The impact of abnormal over-expression of pro-survival BCL-2 proteins as well as abnormally reduced expression of pro-apoptotic BCL-2 family members on tumour development and the resistance of malignant cells to anti-cancer agents are well established [17–19].